Potomac Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Potomac Health News.

Press releases published on July 6, 2026

2 hours ago

Catheter Precision, Inc. Announces Issuance of Two Key Patents

Indeterminate GlobeNewswire

2 hours ago

Belite Bio to Participate in the Piper Sandler Virtual Ophthalmology Investor Symposium

Indeterminate GlobeNewswire

2 hours ago

CervoMed Showcases Leadership in Advancing the Treatment and Care of Dementia with Lewy Bodies at the Alzheimer's Association International Conference (AAIC) 2026

Indeterminate GlobeNewswire

2 hours ago

TG Therapeutics Announces Initiation of Phase 2 Trial Evaluating BRIUMVI in Patients with Treatment-Resistant Schizophrenia

Indeterminate GlobeNewswire

3 hours ago

Pluristyx Inc. Secures Initial Close of Series A Priced Round with Multinational Fortune 500 Company; Round to Remain Open for Syndicate Partners Until September 2nd

Indeterminate GlobeNewswire

3 hours ago

Invivyd Announces Receipt of Twelve Months’ Advanced Notice of Emergency Use Authorization (EUA) Termination for PEMGARDA® and Provides an Update on Next Steps with the U.S. FDA

Indeterminate GlobeNewswire

3 hours ago

VERAXA Biotech Provides Business Update and Further Details on Partnering Strategy and Development Timelines

Indeterminate GlobeNewswire

3 hours ago

Integrated Development Helps Targeted Protein Degraders Reach the Clinic

Indeterminate GlobeNewswire

3 hours ago

Nephros Announces Inclusion in the Russell Microcap® Index

Indeterminate GlobeNewswire

3 hours ago

NovMetaPharma and the FSHD Canada Foundation Establish Collaboration to Advance Cyclo-Z, a First-in-Class Oral Muscle-Preserving Therapy, into Facioscapulohumeral Muscular Dystrophy

Indeterminate GlobeNewswire

3 hours ago

Opus Genetics Announces FDA Alignment on Phase 3 Registrational Trial Design for OPGx-LCA5 in LCA5-Associated Inherited Retinal Disease

Indeterminate GlobeNewswire

3 hours ago

NN, Inc. Announces Major Breakthrough in its Medical Business

Indeterminate GlobeNewswire

3 hours ago

Seer Files Investor Presentation Highlighting Strong Momentum, Commercial Opportunity and Significant Long-Term Value Creation Potential

Indeterminate GlobeNewswire

3 hours ago

Grey Matters Takes Delivery of the First Brain Dedicated PET Scanning System for its Flagship NovaScan Neuroimaging Clinic in Florida

Indeterminate GlobeNewswire

3 hours ago

Belite Bio Announces Oral Presentations at Two Upcoming Medical Conferences

Indeterminate GlobeNewswire

3 hours ago

Can-Fite Achieves Key Pivotal Phase 3 Psoriasis Milestone with Completion of Patient Enrolment for the Interim Analysis: Data Expected Q4 2026/Q1 2027

Indeterminate GlobeNewswire

3 hours ago

Pharvaris Announces FDA Acceptance of New Drug Application for Deucrictibant IR for On-Demand Treatment of Hereditary Angioedema Attacks

Indeterminate GlobeNewswire

4 hours ago

Scilex Holding Company Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP

Indeterminate GlobeNewswire

4 hours ago

Immuron Advances IMM-529 (Clostridioides difficile infection) Partnering Strategy

Indeterminate GlobeNewswire

4 hours ago

AtaiBeckley Doses Last Patient in VLS-01 Phase 2b TRD Study; Plans Phase 3 in Major Depressive Disorder

Indeterminate GlobeNewswire